Pradipta Nabila Kirtti, Ryoto Viensa, Danarti Retno, Budiyanto Arief
Department of Dermatology and Venereology Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta; Dr. Sardjito General Hospital, Yogyakarta, Indonesia.
Dermatol Reports. 2023 May 22;15(4):9708. doi: 10.4081/dr.2023.9708. eCollection 2023 Dec 1.
Narrowband ultraviolet-B (NB-UVB) phototherapy is the mainstay of vitiligo therapy. The response can be evaluated using the vitiligo area scoring index (VASI) and repigmentation grade. However, few studies used VASI to evaluate phototherapy response and there are no definitive data on the reduction of VASI. This retrospective descriptive study aimed to determine the characteristics and decrease of VASI in patients with vitiligo after 36 and 48 sessions of NB-UVB phototherapy, conducted at Dr. Sardjito General Hospital, Yogyakarta, from December 2021-June 2022. The most common predilection was on the face (71.43%) and acral (61.90%). The most common responses after 36 and 48 phototherapy sessions were minimally improved (decrease in VASI<10%) and improved (reduction in VASI 10-25%). The mean decrease in VASI was 18% and 22% after 36 and 48 phototherapy sessions, respectively. 9.52% and 6.67% of patients experienced a reduction in VASI >50% after 36 and 48 phototherapy sessions, respectively. VASI assessment can be used to evaluate the response to phototherapy in vitiligo. However, VASI cannot show a reduction in vitiligo with slight repigmentation in slow-response patients.
窄谱中波紫外线(NB-UVB)光疗是白癜风治疗的主要方法。可使用白癜风面积评分指数(VASI)和色素再生分级来评估疗效。然而,很少有研究使用VASI来评估光疗反应,且关于VASI降低情况尚无确切数据。这项回顾性描述性研究旨在确定2021年12月至2022年6月在日惹市萨迪托综合医院接受36次和48次NB-UVB光疗的白癜风患者的VASI特征及降低情况。最常见的受累部位是面部(71.43%)和肢端(61.90%)。36次和48次光疗后最常见的反应是改善不明显(VASI降低<10%)和改善(VASI降低10%-25%)。36次和48次光疗后VASI的平均降低率分别为18%和22%。36次和48次光疗后分别有9.52%和6.67%的患者VASI降低>50%。VASI评估可用于评估白癜风光疗反应。然而,VASI无法显示反应缓慢且色素再生轻微的白癜风患者的病情减轻情况。